1. ScholarBank@NUS

Ross Andrew Soo

rp03556

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
Main Affiliation
 
Faculty
 
Email
csiras@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Policy:  Open
Subject:  human

Results 1-15 of 15 (Search time: 0.03 seconds).

Issue DateTitleAuthor(s)
12017A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSoh, S.X; Siddiqui, F.J ; Allen, J.C ; Kim, G.W; Lee, J.C; Yatabe, Y; Soda, M; Mano, H; Soo, R.A ; Chin, T.-M ; Ebi, H; Yano, S; Matsuo, K; Niu, X; Lu, S; Isobe, K; Lee, J.-H; Yang, J.C; Zhao, M; Zhou, C; Lee, J.-K; Lee, S.-H; Lee, J.Y; Ahn, M.-J; Tan, T.J; Tan, D.S ; Tan, E.-H; Ong, S.T ; Lim, W.-T 
22017Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysisKoh K.X.; Tan G.H.; Low S.H.H. ; Omar M.F.M. ; Han M.J.; Iacopetta B.; Soo R. ; Beloueche-Babari M.; Bhattacharya B. ; Soong R. 
32016Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentWang, L ; Khoa Phan, D.D; Zhang, J; Ong, P.-S ; Thuya, W.L ; Soo, R.A ; Wong, A.L.-A ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
42017Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Wang, L ; Chan, C.E.L; Wong, A.L.-A ; Wong, F.C; Lim, S.W ; Chinnathambi, A; Alharbi, S.A; Lee, L.S.-U ; Soo, R ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
52018Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samplesSoo, R.A ; Lim, J.S.Y ; Asuncion, B.R ; Fazreen, Z; Herrera, M.C; Omar, M.F.M; Phuong, N.H.D; Seet, J.E ; Amanuel, B; Iacopetta, B; Byrne, D; Hendry, S; Fox, S; Soong, R 
62018Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapyLimviphuvadh, V; Tan, C.S; Konishi, F; Jenjaroenpun, P; Xiang, J.S; Kremenska, Y; Mu, Y.S; Syn, N; Lee, S.C; Soo, R.A ; Eisenhaber, F ; Maurer-Stroh, S ; Yong, W.P 
72018Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerTsui, D.W.Y; Murtaza, M; Wong, A.S.C ; Rueda, O.M; Smith, C.G; Chandrananda, D; Soo, R.A ; Lim, H.L; Goh, B.C ; Caldas, C; Forshew, T; Gale, D; Liu, W; Morris, J; Marass, F; Eisen, T; Chin, T.M ; Rosenfeld, N
82016EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: A retrospective database analysis of potential drug interactionKumarakulasinghe, N.B; Syn, N; Soon, Y.Y; Asmat, A; Zheng, H; Loy, E.Y; Pang, B ; Soo, R.A 
92018Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancerAli, A ; Levantini, E; Teo, J.T ; Goggi, J ; Clohessy, J.G; Wu, C.S ; Chen, L ; Yang, H ; Krishnan, I; Kocher, O; Zhang, J; Soo, R.A ; Bhakoo, K ; Chin, T.M ; Tenen, D.G 
102014Novel SNP improves differential survivability and mortality in non-small cell lung cancer patientsMah, T.L; Yap, X.N.A; Limviphuvadh, V; Li, N; Sridharan, S; Kuralmani, V; Feng, M ; Liem, N; Adhikari, S; Yong, W.P ; Soo, R.A ; Maurer-Stroh, S ; Eisenhaber, F ; Tong, J.C 
112016Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursSoo, R.A ; Syn, N; Lee, S.-C; Wang, L; Lim, X.-Y; Loh, M; Tan, S.-H ; Zee, Y.-K; Wong, A.L.-A ; Chuah, B; Chan, D; Lim, S.-E; Goh, B.-C ; Soong, R ; Yong, W.-P 
122018Prognostic significance of immune cells in non-small cell lung cancer: Meta-analysisSoo, R.A ; Chen, Z; Yan Teng, R.S; Tan, H.-L; Iacopetta, B; Tai, B.C ; Soong, R 
132016Targeting SALL4 by entinostat in lung cancerYong, K.J ; Li, A; Ou, W.-B; Hong, C.K.Y; Zhao, W; Wang, F; Tatetsu, H; Yan, B; Qi, L ; Fletcher, J.A; Yang, H ; Soo, R ; Tenen, D.G ; Chai, L
142018Third generation EGFR TKIs: Current data and future directionsTan, C.-S; Kumarakulasinghe, N.B; Huang, Y.-Q; Ang, Y.L.E; Choo, J.R.-E; Goh, B.-C ; Soo, R.A 
152014Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) non-small cell lung cancer globally?Ou, S.-H.I; Soo, R.A ; Kubo, A; Kawaguchi, T; Ahn, M.-J